StockClub

CMOPF

CMOPFCosmo Pharmaceuticals N.V.$ --
Cosmo Pharmaceuticals N.V.

Cosmo Pharmaceuticals N.V.

CMOPF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
53M EUR
YoY -59.8%
Operating Income
-4M EUR
YoY -107.0%
Net Income
-2M EUR
YoY -102.8%
EPS
-0.1EUR
YoY -102.9%

Revenue

EUR104.2M
FY2022 Q2EUR41.5M
EUR41.5M
Q2
FY2022 Q4EUR102.1M
EUR102.1M
Q4
FY2023 Q2EUR43.7M
EUR43.7M
Q2
FY2023 Q4EUR92.8M
EUR92.8M
Q4
FY2024 Q2EUR136.2M
EUR136.2M
Q2
FY2024 Q4EUR266.8M
EUR266.8M
Q4
FY2025 Q2EUR51.7M
EUR51.7M
Q2
FY2025 Q4EUR104.2M
EUR104.2M
Q4
Actual
EUR-162.5M (-60.9%)

Net Income

EUR-3.6M
FY2022 Q2EUR7.9M
EUR7.9M
Q2
FY2022 Q4EUR17.2M
EUR17.2M
Q4
FY2023 Q2EUR1.5M
EUR1.5M
Q2
FY2023 Q4EUR-4.9M
EUR-4.9M
Q4
FY2024 Q2EUR76M
EUR76M
Q2
FY2024 Q4EUR133.2M
EUR133.2M
Q4
FY2025 Q2EUR-2M
EUR-2M
Q2
FY2025 Q4EUR-3.6M
EUR-3.6M
Q4
Actual
EUR-136.8M (-102.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:EUR60.9M
Est:EUR66.4M
FY2020MISS
EUR60.9M
FY2021MISS
Actual:EUR65.1M
Est:EUR70.5M
FY2021MISS
EUR65.1M
FY2022MISS
Actual:EUR102.1M
Est:EUR107.9M
FY2022MISS
EUR102.1M
FY2023MISS
Actual:EUR92.8M
Est:EUR152.3M
FY2023MISS
EUR92.8M
FY2024BEAT
Actual:EUR266.8M
Est:EUR266.7M
FY2024BEAT
EUR266.8M
FY2025BEAT
Actual:EUR104.8M
Est:EUR102.2M
FY2025BEAT
EUR104.8M

Analyst Estimates